Complement C5a Receptors in Hidradenitis Suppurativa
Actual Study Start Date:
July 18, 2019
Estimated Primary Completion Date: January 20, 2021
Estimated Study Completion Date: July 20, 2021
ID#NCT04251663
Sponsor: Stanford University
Information provided by (Responsible Party): Kavita Sarin, Stanford University
Brief Summary:
To study the role of C5a in Hidradenitis Suppurativa (HS). Complement C5a is a major chemotactic factor that stimulates neutrophil infiltration.
Study Type: Observational
Estimated Enrollment: 20 participants
Complete details to the study link:
https://clinicaltrials.gov/ct2/show/NCT04251663?recrs=a&cond=Hidradenitis&draw=2&rank=9
Location:
Redwood City, California, 94063
Contact:
Clinical Trial Coordinator 650-721-7149